Ensuring Community Access to Pharmacist Services Act

HR3164, the "Ensuring Community Access to Pharmacist Services Act," was introduced in the House of Representatives on May 1, 2025. It was subsequently referred to the Committee on Energy and Commerce and the Committee on Ways and Means. This bill seeks to amend title XVIII of the Social Security Act to provide Medicare Part B payment for certain pharmacist services, specifically for the evaluation and management of individuals for testing or treatment of COVID-19, influenza, respiratory syncytial virus, or streptococcal pharyngitis, and other public health emergency-related services. The bill itself does not appropriate specific funding amounts but rather authorizes the expansion of services covered under Medicare Part B. This means that if enacted, pharmacists would be able to bill Medicare for these services, creating new revenue streams for pharmacies. The mechanism is a change in what Medicare Part B covers, rather than a direct grant or appropriation. Actual reimbursement rates and the volume of services would determine the financial impact. Structural winners, should this bill advance, would primarily be large pharmacy chains and healthcare providers that employ pharmacists, such as CVS Health Corporation ($CVS). These entities would see an expansion of billable services, potentially increasing their overall revenue. UnitedHealth Group Incorporated ($UNH), as a major health insurer and provider, could also be impacted as it manages Medicare Advantage plans, which often follow Medicare Part B coverage guidelines. The bill's early stage and the need for subsequent appropriations or regulatory changes to define reimbursement specifics mean that any financial benefit is not immediate. Looking at recent market data, CVS Health Corporation ($CVS) is currently trading at $73.28, showing a +4.48% change over the last 7 days but a -6.88% change over the last 30 days. UnitedHealth Group Incorporated ($UNH) is at $281.36, with a +7.48% change over 7 days and a -2.57% change over 30 days. These movements are not directly attributable to HR3164 given its early legislative stage. The bill's progression would need to be monitored for any future market reaction. Amazon.com, Inc. ($AMZN) is not directly impacted by this specific healthcare legislation. For HR3164 to become law, it must pass both the House and the Senate and then be signed by the President. Given its referral to two committees in the House and the existence of a related Senate bill (S2426), there is some legislative momentum. However, it is still in the early stages of the committee process, and significant time and debate would be required for further advancement.